Hot Topics: Clinical Questions in Schizophrenia – Question II
Dr. Christoph U. Correll will address current and relevant clinical questions relating to schizophrenia. These questions and Dr. Correll’s response will be recorded and released as short videos.
The use of Long Acting Injectables (LAIs) is included less often overall in the available clinical practice guidelines and less still regarding treatment of first episode schizophrenia patients. Are there advantages to treating a first episode schizophrenia patient with a LAI?
Christoph Correll is a paid consultant for Otsuka Pharmaceutical Development Commercialization, Inc. …